Search research articles
Contact Us
Filters
Showing results (181-190 of 258) with videos related to
Page
of 26
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 10, 1999
Progression of falls in postmortem-confirmed parkinsonian disorders
G K Wenning, G Ebersbach, M Verny, et al.
Archives of Neurology
|
February 15, 2001
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders
J Müller, G K Wenning, M Verny, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1994
Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis
J Hierholzer, M Cordes, L Schelosky, et al.
Journal of Neurology
|
November 8, 2001
Riluzole in Huntington's disease (HD): an open label study with one year follow up
K Seppi, J Mueller, T Bodner, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 29, 2001
Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6
S M Boesch, M Schocke, K Bürk, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
October 1, 1992
[The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients]
J Hierholzer, M Cordes, L Schelosky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 1, 1998
Dose standardization of botulinum toxin
P Krack, G Deuschl, R Benecke, et al.
Neuroscience
|
February 5, 2000
Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts
Z Puschban, C Scherfler, R Granata, et al.
Advances in Neurology
|
January 1, 1993
IBZM-SPECT imaging in Parkinson's disease. Quantification of binding ratios from sequential SPECT measurements in patients and controls
M Cordes, J Hierholzer, L Schelosky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1996
Botulinum toxin in writer's cramp: objective response evaluation in 31 patients
J Wissel, C Kabus, R Wenzel, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 258) with videos related to
Sort By:
Page
of 26
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 10, 1999
Progression of falls in postmortem-confirmed parkinsonian disorders
G K Wenning, G Ebersbach, M Verny, et al.
Archives of Neurology
|
February 15, 2001
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders
J Müller, G K Wenning, M Verny, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1994
Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis
J Hierholzer, M Cordes, L Schelosky, et al.
Journal of Neurology
|
November 8, 2001
Riluzole in Huntington's disease (HD): an open label study with one year follow up
K Seppi, J Mueller, T Bodner, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 29, 2001
Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6
S M Boesch, M Schocke, K Bürk, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
October 1, 1992
[The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients]
J Hierholzer, M Cordes, L Schelosky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 1, 1998
Dose standardization of botulinum toxin
P Krack, G Deuschl, R Benecke, et al.
Neuroscience
|
February 5, 2000
Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts
Z Puschban, C Scherfler, R Granata, et al.
Advances in Neurology
|
January 1, 1993
IBZM-SPECT imaging in Parkinson's disease. Quantification of binding ratios from sequential SPECT measurements in patients and controls
M Cordes, J Hierholzer, L Schelosky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1996
Botulinum toxin in writer's cramp: objective response evaluation in 31 patients
J Wissel, C Kabus, R Wenzel, et al.
Page
of 26